EUVIMEDEUVIMED entdecken
Crossref

Phthalimides Represent a Promising Scaffold for Multi‐Targeted Anticancer Agents

Balaji Wamanrao Matore, Purusottam Banjare, Ajay Singh Sarthi, Partha Pratim Roy, Jagadish Singh

ChemistrySelect · 06.03.2023 · 8 (9)

DOI: 10.1002/slct.202204851 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemistrySelect, online erschienen am 28.02.2023. Verfasst von Balaji Wamanrao Matore und 4 weiteren Autor:innen. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 85 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

From the last two decades, phthalimide analogues received prime interest from scientists due to its potent inhibitory action on different cancer‐causing receptors. A variety of anticancer drugs are coming into the market but challenges of drug resistance, toxicities, and failure in therapy still remain. Cancer is a group of complex disorders it involves multiple receptors. So there is a need of targeting multiple receptors to get desired potent anticancer drugs with minimum harmful effects. Phthalimide scaffolds fit into these criteria as it is extensively reported for the inhibition of different cancer receptors such as VEGFR, HDAC, EGFR, TNF‐α, etc. The multi‐targeted mechanism of phthalimide derivatives plays a major role in anticancer therapy. Due to this advantage, there is the hope of developing some novel effective multi‐targeted anticancer agents. Consider structural features and pharmacological advancement of phthalimide analogues may fulfill the current need of cancer patients. In this review, we covered history, chemistry, SAR, anticancer mechanisms, and the current status of phthalimide derivatives reported till 2022. The article specifically focused on different cancer‐causing receptors inhibited by phthalimide derivatives and their mechanism of action in brief. Finally, we provided the future scope and role of phthalimide derivatives in multi‐targeted anticancer drug discovery.

Zitieren

APA

Matore, B. W., Banjare, P., Sarthi, A. S., Roy, P. P., & Singh, J. (2023). Phthalimides Represent a Promising Scaffold for Multi‐Targeted Anticancer Agents. ChemistrySelect, 8(9). https://doi.org/10.1002/slct.202204851

Vancouver

Matore BW, Banjare P, Sarthi AS, Roy PP, Singh J. Phthalimides Represent a Promising Scaffold for Multi‐Targeted Anticancer Agents. ChemistrySelect. 2023;8(9). doi:10.1002/slct.202204851

BibTeX
@article{Matore2023,
  author = {Matore, Balaji Wamanrao and Banjare, Purusottam and Sarthi, Ajay Singh and Roy, Partha Pratim and Singh, Jagadish},
  title = {Phthalimides Represent a Promising Scaffold for Multi‐Targeted Anticancer Agents},
  journal = {ChemistrySelect},
  year = {2023},
  volume = {8},
  number = {9},
  doi = {10.1002/slct.202204851}
}
Kostenlos starten →